Impact of cancer history on long-term outcome after elective neuro-endovascular treatment in patients aged 80 years or older: A retrospective multicenter observational study

AimAssessing the indication for elective neuro-endovascular treatment (EVT) in older patients requires consideration of the impact of systemic comorbidities on their overall reduced life expectancy. The objective of this study was to determine the long-term outcomes of elective neuro-EVT in patients aged >= 80 years, and to investigate the impact of pre-existing cancer on their long-term outcomes.MethodsOf the patients enrolled in multicenter observational registry, those aged >= 80 years undergoing elective neuro-EVT between 2011 and 2020 were enrolled. A history of cancer was defined as a pre-existing solid or hematologic malignancy at the time of EVT. The primary outcome was time to death from elective neuro-EVT.ResultsOf the 6183 neuro-EVT cases implemented at 10 stroke centers, a total of 289 patients (median age, 82 years [interquartile range 81-84 years]) were analyzed. A total of 58 (20.1%) patients had a history of cancer. A total of 78 patients (27.0%) died during follow up. The 5-year survival rate of enrolled patients was 64.6%. Compared with patients without a history of cancer, those with a history of cancer showed significantly worse survival (log-rank test, P = 0.001). Multivariate Cox proportional hazards analysis showed history of cancer was an independent predictor of time to death from elective neuro-EVT (HR 1.74, 95% CI 1.01-3.00, P = 0.047). Cancer was the leading cause of death, accounting for 25.6% of all deaths.ConclusionsThe present study showed that history of cancer has a significant impact on time to death from elective neuro-EVT in patients aged >= 80 years. Geriatr Gerontol Int 2023; center dot center dot: center dot center dot-center dot center dot. The 5-year survival rate after elective neuro-endovascular treatment in patients aged >= 80 years was 64.6%. History of cancer was an independent predictor of time to death from elective neuro-endovascular treatment. History of cancer also seemed to have an impact on the causes of death in those patients.image